- Home
- LNTH vs VEON Comparison
LNTH vs VEON Comparison
Compare LNTH & VEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LNTH | VEON |
|---|---|---|
| Founded | 1956 | 1992 |
| Country | United States | United Arab Emirates |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.7B |
| IPO Year | 2015 | 1996 |
Fundamental Metrics
Financial Performance| Metric | LNTH | VEON |
|---|---|---|
| Price | $63.31 | $50.14 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $74.17 | $73.25 |
| AVG Volume (30 Days) | ★ 1.1M | 118.8K |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 2.39 | ★ 8.91 |
| Revenue | $1,525,933,000.00 | ★ $4,226,000,000.00 |
| Revenue This Year | $0.01 | $10.26 |
| Revenue Next Year | $1.24 | $7.61 |
| P/E Ratio | $26.45 | ★ $5.65 |
| Revenue Growth | 1.95 | ★ 6.74 |
| 52 Week Low | $47.25 | $34.05 |
| 52 Week High | $111.29 | $64.00 |
Technical Indicators
Market Signals| Indicator | LNTH | VEON |
|---|---|---|
| Relative Strength Index (RSI) | 71.16 | 48.74 |
| Support Level | $57.44 | $48.68 |
| Resistance Level | $59.30 | $54.66 |
| Average True Range (ATR) | 2.14 | 1.98 |
| MACD | 0.82 | -0.05 |
| Stochastic Oscillator | 91.35 | 36.64 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About VEON VEON Ltd. ADS
VEON Ltd is a United Arab Emirates-based digital operator providing connectivity and Internet services to corporations and individuals. The company offers mobile and fixed-line telecommunications services through a range of traditional and broadband mobile technologies. The company's reportable segments consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. It provides its services under the Beeline, Kyivstar, Banglalink, and Jazz brands. It generates the majority of its revenue from Pakistan.